Literature DB >> 10489934

Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects.

E Gaudio1, G Taddei, A Vetuschi, R Sferra, G Frieri, G Ricciardi, R Caprilli.   

Abstract

Aim of this study was to assess the structural, ultrastructural, immunohistochemical, and clinical aspects in Sprague-Dawley rats with dextrane sulfate sodium (DSS)-induced colitis. Colitis was induced in Sprague-Dawley rats by seven days of DSS oral administration followed by seven days of tap water only (for one, two and three cycles). Controls were fed with water only. Segments of proximal, mid-, and distal colon of each animal were adequately prepared for light and scanning electron microscope observations. The severity of the lesions was scored histologically. For immunohistochemical study, a cocktail of S-100, NSE, and antineurofilament antibodies was used. Symptoms such as weight, feces consistency, diarrhea, hematochezia were recorded daily. From a clinical point of view symptoms appeared significantly later after the first cycle than after the second and third cycles and lasted significantly longer in the second and third cycles. Treated rats showed a slower weight gain rate by 20% compared to controls, and the whole colon length appeared to be significantly shorter after colitis induction compared to controls. Structural observations by light microscopy showed prominent involvement of the distal colon. Immunohistochemical study of both submucosal and myoenteric nerve plexuses was similar to controls. Scanning electron microscope observations of the colonic mucosal surface in colitis rats showed a complete subversion of its architecture, characterized by dilatations of gland crypt openings, dropout of goblet cells, and inhomogeneous distribution or lack of microvilli. These were most evident after the third cycle. In conclusion, experimental DSS colitis in SD rats appeared to be highly reproducible and shared most features with human UC, not only from a structural and clinical but also from an ultrastructural point of view.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10489934     DOI: 10.1023/a:1026620322859

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

1.  [Ulcerative colitis: the ultrastructural and differential diagnostic aspects].

Authors:  E Trabucchi; M Pace; G Micheletto; P Abelli; E Radaelli; D Foschi
Journal:  Minerva Chir       Date:  1992-03-31       Impact factor: 1.000

2.  Neuropeptides in inflammatory bowel disease: an update.

Authors:  M Reinshagen; B Egger; F Procaccino; V E Eysselein
Journal:  Inflamm Bowel Dis       Date:  1997       Impact factor: 5.325

Review 3.  Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

Authors:  R B Sartor
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

4.  Ultrastructural pathology of Crohn's disease: correlated transmission electron microscopy, scanning electron microscopy, and freeze fracture studies.

Authors:  M L Marin; S A Geller; A J Greenstein; R H Marin; R E Gordon; A H Aufses
Journal:  Am J Gastroenterol       Date:  1983-06       Impact factor: 10.864

5.  Histochemical study of colonic cancer in experimental colitis of rats.

Authors:  T Tamaru; H Kobayashi; S Kishimoto; G Kajiyama; F Shimamoto; W R Brown
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

6.  Scanning electron microscopic appearance of chronic ulcerative colitis with and without dysplasia.

Authors:  H M Shields; M L Bates; H Goldman; G R Zuckerman; B A Mills; C J Best; F A Bair; D A Goran; K DeSchryver-Kecskemeti
Journal:  Gastroenterology       Date:  1985-07       Impact factor: 22.682

7.  Differential diagnosis of Crohn's disease of the colon from ulcerative colitis: ultrastructure study with the scanning electron microscope.

Authors:  E Trabucchi; S Mukenge; C Baratti; R Colombo; F Fregoni; W Montorsi
Journal:  Int J Tissue React       Date:  1986

8.  Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis.

Authors:  S Kishimoto; H Kobayashi; S Shimizu; K Haruma; T Tamaru; G Kajiyama; A Miyoshi
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

9.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.

Authors:  L A Dieleman; B U Ridwan; G S Tennyson; K W Beagley; R P Bucy; C O Elson
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

10.  Scanning electron microscopy of Crohn's disease and ulcerative colitis of the colon.

Authors:  H Myllärniemi; J Nickels
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980
View more
  86 in total

1.  Emu oil increases colonic crypt depth in a rat model of ulcerative colitis.

Authors:  Suzanne M Abimosleh; Ruth J Lindsay; Ross N Butler; Adrian G Cummins; Gordon S Howarth
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice.

Authors:  Xiaochang Liu; Jianming Xu; Qiao Mei; Liang Han; Jian Huang
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

3.  Dextran sulfate sodium-induced colitis is associated with enhanced low molecular mass polypeptide 2 (LMP2) expression and is attenuated in LMP2 knockout mice.

Authors:  Leo R Fitzpatrick; Vineeta Khare; Jeffrey S Small; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

4.  NF-kappaB activation precedes increases in mRNA encoding neurokinin-1 receptor, proinflammatory cytokines, and adhesion molecules in dextran sulfate sodium-induced colitis in rats.

Authors:  Karen L Reed; A Brent Fruin; Adam C Gower; Kelly D Gonzales; Arthur F Stucchi; Christopher D Andry; Michael O'Brien; James M Becker
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

5.  Increased serum levels of L-arginine in ulcerative colitis and correlation with disease severity.

Authors:  Shih-Kuang S Hong; Brad E Maltz; Lori A Coburn; James C Slaughter; Rupesh Chaturvedi; David A Schwartz; Keith T Wilson
Journal:  Inflamm Bowel Dis       Date:  2010-01       Impact factor: 5.325

6.  Development of colorectal sensitization is associated with increased eosinophils and mast cells in dextran sulfate sodium-treated rats.

Authors:  J M Tobin; L M D Delbridge; R Di Nicolantonio; P Bhathal
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

7.  Sodium arsenite reduces severity of dextran sulfate sodium-induced ulcerative colitis in rats.

Authors:  Joshua J Malago; Hortensia Nondoli
Journal:  J Zhejiang Univ Sci B       Date:  2008-04       Impact factor: 3.066

8.  Structural changes in the epithelium of the small intestine and immune cell infiltration of enteric ganglia following acute mucosal damage and local inflammation.

Authors:  Louise Pontell; Patricia Castelucci; Mária Bagyánszki; Tanja Jovic; Michelle Thacker; Kulmira Nurgali; Romke Bron; John B Furness
Journal:  Virchows Arch       Date:  2009-06-11       Impact factor: 4.064

9.  Expression of alkaline sphingomyelinase in yeast cells and anti-inflammatory effects of the expressed enzyme in a rat colitis model.

Authors:  David Andersson; Knut Kotarsky; Jun Wu; William Agace; Rui-Dong Duan
Journal:  Dig Dis Sci       Date:  2008-11-07       Impact factor: 3.199

10.  Omega-3 fatty acids in the maintenance of ulcerative colitis.

Authors:  Cinzia Papadia; Alessandro Coruzzi; Chiara Montana; Francesco Di Mario; Angelo Franzè; Alastair Forbes
Journal:  JRSM Short Rep       Date:  2010-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.